Infection of human pegivirus 2 (HPgV-2) is associated with hepatitis C virus but not hepatitis B virus infection in people who inject drugs

References

1. Berg MG, Lee D, Coller K, Frankel M, Aronsohn A et al. Discovery of a novel human Pegivirus in blood associated with hepatitis C virus co-infection. PLoS Pathog 2015; 11:e1005325 [View Article]
   [Google Scholar]
2. Kapoor A, Kumar A, Simmonds P, Bhuva N, Singh Chauhan L et al. Virome analysis of transfusion recipients reveals a novel human virus that shares genomic features with Hepaciviruses and Pegiviruses. MBio 2015; 6:e01466–01415 [View Article]
   [Google Scholar]
3. Bonsall D, Gregory WF, Ip CLC, Donfield S, Iles J et al. Evaluation of viremia frequencies of a novel human Pegivirus by using bioinformatic screening and PCR. Emerg Infect Dis 2016; 22:671–678 [View Article]
   [Google Scholar]
4. Wang H, Wan Z, Xu R, Guan Y, Zhu N et al. A novel human Pegivirus, HPgV-2 (HHpgV-1), is tightly associated with hepatitis C virus (HCV) infection and HCV/Human immunodeficiency virus type 1 coinfection. Clin Infect Dis 2018b; 66:29–35 [View Article]
   [Google Scholar]
5. Bijvand Y, Aghasadeghi MR, Sakhaee F, Pakzad P, Vaziri F et al. First detection of human hepegivirus-1 (HHpgV-1) in Iranian patients with hemophilia. Sci Rep 2018; 8:5036 [View Article]
   [Google Scholar]
6. Rodgers MA, Holzmayer V, Vallari A, Olivo A, Forberg K et al. Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort. J Viral Hepat 2019; 26:30–37 [View Article]
   [Google Scholar]
7. Anh NT, Hong NTT, Nhu LNT, Thanh TT, Anscombe C et al. Detection and characterization of human Pegivirus 2, Vietnam. Emerg Infect Dis 2018; 24:2063–2067 [View Article]
   [Google Scholar]
8. Kandathil AJ, Breitwieser FP, Sachithanandham J, Robinson M, Mehta SH et al. Presence of human Hepegivirus-1 in a cohort of people who inject drugs. Ann Intern Med 2017; 167:1–7 [View Article]
   [Google Scholar]
9. Wang H, Wan Z, Sun Q, Zhu N, Li T et al. Second human Pegivirus in hepatitis C virus-infected and hepatitis C Virus/HIV-1-Co-infected persons who inject drugs, China. Emerg Infect Dis 2018a; 24:908–911 [View Article]
   [Google Scholar]
10. Tang S, Wang H. Presence of human hepegivirus-1 in a cohort of people who inject drugs. Ann Intern Med 2018; 168:157–158 [View Article]
    [Google Scholar]
11. Chen F, Zhang J, Wen B, Luo S, Lin Y et al. HBV/HCV dual infection impacts viral load, antibody response, and cytokine expression differently from HBV or HCV single infection. Sci Rep 2016; 6:39409 [View Article]
    [Google Scholar]
12. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11:791–796 [View Article]
    [Google Scholar]
13. Li Q, Yao Y, Shen Y, Cao D, Li Y et al. Assessment of HCV genotypes in Yunnan Province of Southwest China. Virus Genes 2017; 53:190–196 [View Article]
    [Google Scholar]
14. Coller KE, Berg MG, Frankel M, Forberg K, Surani R et al. Antibodies to the novel human Pegivirus 2 are associated with active and resolved infections. J Clin Microbiol 2016; 54:2023–2030 [View Article]
    [Google Scholar]
15. Lee M-H, Hsiao TI, Subramaniam SR, Le AK, Vu VD et al. HCV genotype 6 increased the risk for hepatocellular carcinoma among Asian patients with liver cirrhosis. Am J Gastroenterol 2017; 112:1111–1119 [View Article]
    [Google Scholar]
16. Chu C-M, Yeh CT, Sheen IS, Liaw YF. Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV. Gut 2002; 51:95–99 [View Article]
    [Google Scholar]
17. Pestka JM, Zeisel MB, Bläser E, Schürmann P, Bartosch B et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci U S A 2007; 104:6025–6030 [View Article]
    [Google Scholar]